| New from NCI |
| Facebook Live Event about Cervical Cancer Treatment |
 | | Thursday, January 26, 2017 at 2:00 p.m.
NCI's Dr. Christina Annunziata and Dr. Sarah Temkin from Virginia Commonwealth University will discuss cervical cancer treatment and clinical trials. |
| For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain |
 | | Results of a randomized clinical trial show that a drug most commonly used to treat depression may also reduce joint pain caused by drugs used to prevent breast cancer from returning. |
Relief for Chronic Graft-Versus-Host Disease Symptoms
A small clinical trial shows that ibrutinib can treat symptoms of chronic graft-versus-host disease. Ibrutinib is a targeted cancer therapy. |
Mammogram Fact Sheet
We’ve updated this fact sheet to include the latest information about factors related to false-positive test results, categories of breast density that require reporting, and two new research studies. |
| Drug Information Updates |
New Drug for Ovarian Cancer
We've added a new drug summary for rucaparib camsylate. It was recently approved by the Food and Drug Administration (FDA) to treat advanced ovarian cancer with BRCA1 or BRCA2 gene mutations in patients who have already been treated with chemotherapy. |
.png)
No hay comentarios:
Publicar un comentario